l.diallo
TL2 Moderator · Plovdiv
Contributes reviews on supplier material. Based in Plovdiv.
Joined 21 October 2024 · last posted 4d
65 posts, newest first. Showing up to 150.
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #23 · Compounds › Oral incretins · 24 Jul 2026 · 5 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #94 · Evidence › Journal club · 21 Jul 2026 · 7 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Pages past their review date, listed — does this still hold? Replied, post #53 · Meta › Wiki maintenance · 15 Jul 2026 · 0 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
-
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #17 · Analytics › HPLC & UHPLC · 12 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #66 · Analytics › Home & field testing · 8 Jul 2026 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #24 · Compounds › Semaglutide · 26 Jun 2026 · 7 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #99 · Outcomes › Body composition · 20 Jun 2026 · 0 likes Worth separating two things that post #95 runs together. Changes during titration: measuring body composition during active titration is less useful than measuring…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #30 · Sourcing › Independent verification · 20 Jun 2026 · 14 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
About the Mass spectrometry category Replied, post #3 · Analytics › Mass spectrometry · 13 Jun 2026 · 23 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #46 · Practice › Dosing & titration · 22 May 2026 · 21 likes Picking up post #43: that is the part I would want checked first. Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #25 · Compounds › Repair & healing peptides · 14 May 2026 · 33 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Request: show the solution author in the topic list — what changed since Replied, post #88 · Meta › Feature requests · 4 May 2026 · 5 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
-
Spike-and-recover accuracy for a peptide assay Replied, post #23 · Analytics › Method validation · 7 Apr 2026 · 3 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Prescription portability between countries Replied, post #3 · Access › International · 6 Apr 2026 · 13 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #7 · Data & Tools › Calculators · 1 Apr 2026 · 15 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Reading a syringe in poor light, and how to avoid needing to — what changed since Replied, post #3 · Devices › Syringes & needles · 21 Mar 2026 · 3 likes Picking up post #2: that is the part I would want checked first. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #29 · Lounge › Introductions · 10 Mar 2026 · 5 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #4 · Evidence › Trials · 8 Mar 2026 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #90 · Access › Pricing · 15 Feb 2026 · 0 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
A plateau that disappeared when I changed how I measured Replied, post #12 · Outcomes › Progress reports · 31 Jan 2026 · 2 likes This follows post #9 rather than contradicting it. Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents…
-
Request: a diff view for wiki revisions — the long version Replied, post #105 · Meta › Feature requests · 25 Jan 2026 · 13 likes Requests for platform and documentation features, with the reasoning that justifies them. If you think the site would be better with a feature, suggest it with enough…
-
Recording a dissent on a document rather than suppressing it Replied, post #2 · Documentation › Doc review · 16 Jan 2026 · 7 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Research-use-only labelling: what it means and what it does not Replied, post #84 · Sourcing › Regulatory · 7 Jan 2026 · 17 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #6 · Compounds › Secretagogues & GH axis · 2 Jan 2026 · 0 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #34 · Sourcing › Red flags · 1 Jan 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #42 · Access › Pricing · 21 Dec 2025 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Guidelines revision: what changed and why — one year on Replied, post #45 · Meta › Announcements · 11 Dec 2025 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #65 · Compounds › Semaglutide · 9 Dec 2025 · 21 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #74 · Practice › Reconstitution · 26 Nov 2025 · 18 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #53 · Compounds › Other compounds · 24 Nov 2025 · 5 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #8 · marked as the solution · Start Here › Welcome · 12 Nov 2025 · 6 likes I read post #6 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #15 · Compounds › Retatrutide · 10 Nov 2025 · 0 likes Worth separating two things that post #11 runs together. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose.…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #29 · Start Here › How to Ask · 4 Nov 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Which panel is worth repeating and which is worth ignoring Replied, post #134 · Clinical › Bloodwork · 10 Oct 2025 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #30 · Clinical › Special populations · 3 Oct 2025 · 8 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #39 · Compounds › Oral incretins · 17 Sep 2025 · 0 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Documenting an adverse event properly Replied, post #5 · Safety › Adverse events · 12 Sep 2025 · 31 likes Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation) warrant urgent evaluation. Severe dehydration during weight loss is a…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #7 · Compounds › Tirzepatide · 9 Sep 2025 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #34 · Evidence › Journal club · 20 Aug 2025 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
What this community means by "a source", in practical terms Replied, post #65 · Start Here › Welcome · 9 Aug 2025 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #4 · Practice › Reconstitution · 25 May 2025 · 5 likes Worth separating two things that post #3 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #126 · Sourcing › Independent verification · 20 May 2025 · 28 likes Coming back to post #124, because the follow-up matters more than the original answer. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
A claim built entirely on a subgroup analysis Replied, post #31 · Evidence › Study critique · 12 May 2025 · 25 likes This follows post #28 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Scheduled maintenance and what will be unavailable Replied, post #126 · Meta › Announcements · 28 Apr 2025 · 0 likes Coming back to post #124, because the follow-up matters more than the original answer. Staff announcements, policy changes, and scheduled maintenance. Read-only except…
-
Follow-up: What other technical communities get right that we do not Replied, post #56 · Lounge › Off topic · 2 Apr 2025 · 0 likes On post #52 — agreed on the reasoning, with one qualification. Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a…
-
Ipamorelin selectivity claims and where they came from Replied, post #21 · Compounds › Secretagogues & GH axis · 18 Mar 2025 · 0 likes Coming back to post #19, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Maintainer handover: how it works Replied, post #40 · Meta › Wiki maintenance · 16 Mar 2025 · 29 likes Picking up post #37: that is the part I would want checked first. Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned.…
-
When to suspect the method rather than the sample Replied, post #81 · Analytics › Method validation · 13 Feb 2025 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Consistent declarations and why they matter more than clever ones Replied, post #13 · Sourcing › Logistics · 9 Feb 2025 · 0 likes post #12 is right about the mechanism and I think understates the practical bit. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #50 · Compounds › Secretagogues & GH axis · 25 Jan 2025 · 32 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
A supplier that answers analytical questions with restated claims Replied, post #9 · Sourcing › Red flags · 12 Jan 2025 · 12 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Individual participant data versus aggregate data Replied, post #92 · Evidence › Meta-analyses · 11 Jan 2025 · 3 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #51 · Compounds › Semaglutide · 28 Dec 2024 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Here for the analytics and not much else — one year on Replied, post #10 · Lounge › Introductions · 25 Dec 2024 · 13 likes I read post #8 twice before replying, because I had assumed the opposite. Say hello. No question required. Introduce yourself if you want to give context for why you…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #13 · Compounds › Semaglutide · 18 Dec 2024 · 4 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Body image changing more slowly than the body Replied, post #50 · Wellbeing › Mental health · 16 Dec 2024 · 28 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Time to steady state after a dose increase Replied, post #12 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #6 · Access › Insurance & coverage · 27 Oct 2024 · 8 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Promotion criteria, and the one that stops most nominations Replied, post #82 · Documentation › Doc review · 10 Oct 2024 · 30 likes post #81 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #69 · Practice › Administration · 1 Oct 2024 · 3 likes Worth separating two things that post #65 runs together. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #4 · Wellbeing › Mental health · 24 Sep 2024 · 0 likes post #2 answers the question as asked. The question underneath it is different. Support and community: some people process weight change through community (online or…
-
Blind submission and why it changes minds Replied, post #24 · Sourcing › Independent verification · 28 Jul 2024 · 32 likes post #23 answers the question as asked. The question underneath it is different. Service differences on vendor pages: Janoshik and Medutest results are measurements on…
-
Guidelines revision: what changed and why Replied, post #62 · Meta › Announcements · 26 Jul 2024 · 2 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #67 · Practice › Dosing & titration · 8 Jul 2024 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The mass-error checker and its intended scope Replied, post #45 · Data & Tools › Calculators · 12 Jun 2024 · 0 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…